ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,815Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1802

$584K Total Retail Price of All Prescriptions

Rank: 56 out of 1802

479 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 479 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,074 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
FUROSEMIDE 475 420 1 5
OMEPRAZOLE 436 344 2 4
LEVOTHYROXINE SODIUM 395 319 3 2
SIMVASTATIN 301 239 4 1
CITALOPRAM HBR 274 249 5 17
AMLODIPINE BESYLATE 247 226 6 6
LOSARTAN POTASSIUM 238 201 7 18
WARFARIN SODIUM 225 203 8 7
LISINOPRIL 223 193 9 3
METOPROLOL TARTRATE 216 196 10 9
PRAVASTATIN SODIUM 206 195 11 19
HYDROCHLOROTHIAZIDE 179 167 12 8
METOPROLOL SUCCINATE 174 155 13 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 173 127 14 23
HYDROCODONE-ACETAMINOPHEN 165 136 S3 15 10
POTASSIUM CHLORIDE 163 136 16 15
LOVASTATIN 162 139 17 25
METFORMIN HCL 156 125 18 11
ALENDRONATE SODIUM 149 149 19 21
ADVAIR DISKUS 145 120 20 32
ATORVASTATIN CALCIUM 139 102 21 14
GABAPENTIN 128 103 22 16
ATENOLOL 127 119 23 12
SERTRALINE HCL 105 95 24 20
METFORMIN HCL ER 103 75 25 46
ALLOPURINOL 102 89 26 24
PREDNISONE 100 92 27 33
NAMENDA 100 90 27 34
DIOVAN 96 92 29 57
FENTANYL 95 95 S2 30 43
FLUOXETINE HCL 94 56 31 35
RANITIDINE HCL 93 67 32 30
LANTUS SOLOSTAR 93 57 32 63
CLOPIDOGREL 84 67 34 48
TAMSULOSIN HCL 83 83 35 28
DONEPEZIL HCL 78 72 36 26
FLUTICASONE PROPIONATE 76 67 37 37
MIRTAZAPINE 75 63 38 38
GLIMEPIRIDE 70 67 39 42
KLOR-CON M20 68 68 40 86
LOSARTAN-HYDROCHLOROTHIAZIDE 67 57 41 52
CARVEDILOL 66 66 42 36
NEXIUM 64 45 43 50
SPIRONOLACTONE 61 49 44 53
PROAIR HFA 59 33 45 58
POLYETHYLENE GLYCOL 3350 58 37 46 29
PEN NEEDLE 58 39 46 124
TRAZODONE HCL 57 57 48 39
CRESTOR 57 55 48 31
PANTOPRAZOLE SODIUM 57 37 48 44
LANTUS 56 50 51 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 37 52 135
TORSEMIDE 52 51 52 181
ZOLPIDEM TARTRATE 52 52 52 27
CYMBALTA 51 41 55 75
AMITRIPTYLINE HCL 51 26 R 55 80
TRIAMTERENE-HCTZ 50 47 57 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.